Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
66M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
11.6M
-
Shares change
-
+1.11M
-
Total reported value, excl. options
-
$177M
-
Value change
-
+$14.5M
-
Number of buys
-
34
-
Number of sells
-
-24
-
Price
-
$15.25
Significant Holders of Neuronetics, Inc. - Common Stock, par value $0.01 per share (STIM) as of Q1 2019
68 filings reported holding STIM - Neuronetics, Inc. - Common Stock, par value $0.01 per share as of Q1 2019.
Neuronetics, Inc. - Common Stock, par value $0.01 per share (STIM) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.6M shares
of 66M outstanding shares and own 17.6% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (1.67M shares), New Leaf Venture Partners, L.L.C. (1.54M shares), INTERWEST VENTURE MANAGEMENT CO (1.03M shares), BlackRock Inc. (921K shares), Polaris Venture Management Co. V, L.L.C. (742K shares), Novo Holdings A/S (525K shares), VANGUARD GROUP INC (430K shares), LORD, ABBETT & CO. LLC (418K shares), FRANKLIN RESOURCES INC (416K shares), and WELLS FARGO & COMPANY/MN (329K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.